Description
IGF-LR3 + BPC-157 + Thymosin Beta-4 Stack research blend
IGF-LR3 + BPC-157 + Thymosin Beta-4 Stack combines IGF-1 LR3, BPC-157 and TB-500, supplied as spray or lyophilised peptide.
Product details
| Compound | IGF-1 LR3, BPC-157 and TB-500 |
|---|---|
| Class | Three-peptide research blend |
| Form | Nasal Spray (IGF-LR3 + BPC-157 + TB-500); Peptide (IGF-LR3 + BPC-157 + TB-500); Nasal Spray (IGF-LR3 + BPC-157 Arg + TB-500); Peptide (IGF-LR3 + BPC-157 Arg + TB-500) |
| Strength | 450mcg per spray/10ml/45mg; 11mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What IGF-LR3 + BPC-157 + Thymosin Beta-4 Stack research has examined
- IGF-1 LR3: IGF-1 receptor signalling.
- BPC-157: gastrointestinal and tendon models.
- TB-500: cell-migration models.
Research interest does not establish a proven effect in humans.
Regulatory status
IGF-LR3 + BPC-157 + Thymosin Beta-4 Stack is a research blend. None of its components is approved for human use in this form, and it is supplied as a research chemical only.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Healing and Repair Research Blend: BPC-157 Arg + Thymosin Beta-4 + GHK-Cu · IGF-LR3 + BPC-157 Blend · BPC-157 Acetate + TB-500 Fragment 17-23 Blend · All peptide sprays
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.